Want to join the conversation?
$AMGN announced results from new retrospective analyses of key studies with Vectibix in metastatic colorectal cancer (mCRC) patients. The new retrospective analyses confirm Vectibix treatment provided survival benefit over chemotherapy with or without bevacizumab in metastic colorectal cancer patients with tumors of left-sided origin.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.